ncRNA statistic
| miRNA | Freq | Target | Pathway |
|---|---|---|---|
| miR-124 | 34 | ||
| miR-155 | 27 | ||
| miR-146a | 17 | ||
| miR-21 | 8 | ||
| let-7a | 7 | ||
| miR-124-3p | 6 | ||
| miR-223 | 6 | ||
| miR-146a-5p | 5 | ||
| miR-181c | 5 | ||
| miR-221 | 5 | ||
| miR-9 | 5 | ||
| miR-34a | 4 | ||
| miR-125b | 3 | ||
| miR-181a | 3 | ||
| miR-195 | 3 | ||
| miR-200b | 3 | ||
| miR-222 | 3 | ||
| miR-26a | 3 | ||
| miR-29b | 3 | ||
| miR-93 | 3 | ||
| miR-98 | 3 | ||
| let-7b | 2 | ||
| let-7c-5p | 2 | ||
| miR-101 | 2 | ||
| miR-135a-5p | 2 | ||
| miR-138 | 2 | ||
| miR-142-3p | 2 | ||
| miR-143 | 2 | ||
| miR-144 | 2 | ||
| miR-150 | 2 | ||
| miR-155-5p | 2 | ||
| miR-15a | 2 | ||
| miR-17 | 2 | ||
| miR-204 | 2 | ||
| miR-21-5p | 2 | ||
| miR-210 | 2 | ||
| miR-214-5p | 2 | ||
| miR-223-5p | 2 | ||
| miR-24-3p | 2 | ||
| miR-30a-5p | 2 | ||
| miR-32-5p | 2 | ||
| miR-367 | 2 | ||
| miR-429 | 2 | ||
| miR-451 | 2 | ||
| miR-7 | 2 | ||
| H19 | 6 | ||
| MALAT1 | 6 | ||
| XIST | 5 | ||
| lincRNA-Cox2 | 3 | ||
| NEAT1 | 3 | ||
| SNHG1 | 3 | ||
| SNHG14 | 3 | ||
| FIRRE | 2 | ||
| GAS5 | 2 | ||
| HOXA11-AS | 2 | ||
| MEG3 | 2 | ||
| SNHG15 | 2 | ||
| SNHG5 | 2 | ||
| SNHG8 | 2 | ||
| TUG1 | 2 | ||
| circPTK2 | 2 |
pathway statistic
| Pathway | counts |
|---|---|
| 25 | |
| 6 | |
| 3 | |
| 3 | |
| 3 | |
| 2 | |
| 2 | |
| 2 | |
| 2 | |
| 2 | |
| 2 |
model statistic
| Model | counts |
|---|---|
| 29 | |
| 20 | |
| 19 | |
| 17 | |
| 17 | |
| 13 | |
| 13 | |
| 13 | |
| 12 | |
| 9 | |
| 7 | |
| 6 | |
| 6 | |
| 5 | |
| 5 | |
| 4 | |
| 4 | |
| 4 | |
| 4 | |
| 3 | |
| 3 | |
| 3 | |
| 3 | |
| 3 | |
| 3 | |
| 2 | |
| 2 | |
| 2 | |
| 2 | |
| 2 | |
| 2 | |
| 2 | |
| 2 | |
| 2 | |
| 2 |
ncRNA profiles statistic
| GSEid | GPL | Species | RNA | Sample | Group_1 | Group_2 | Group_3 | Details |
|---|---|---|---|---|---|---|---|---|
| GSE34614 | GPL10344 | Rattus norvegicus | miRNA | 13 | cell type | neuron/microglia | cell_type: neurons and microglia(3vs3) | |
| cell type | astrocytes/microglia | cell_type: astrocytes and microglia(4vs3) | ||||||
| cell type | oligodendrocytes/microglia | cell_type: oligodendrocytes and microglia(3vs3) | ||||||
| GSE35706 | GPL15216 | Mus musculus | miRNA | 12 | treatment | virus infection | RABV/mock | treatment: CVS11 and mock(8vs8) |
| treatment | virus infection | RABV12h/mock12h | time: 12 CVS11 and mock(2vs2) | |||||
| treatment | virus infection | RABV24h/mock24h | time: 24 CVS11 and mock(4vs4) | |||||
| treatment | virus infection | RABV48h/mock48h | time: 48 CVS11 and mock(2vs2) | |||||
| treatment | virus infection | RABV12h/RABV24h | treatment: CVS11 12 and 24(2vs4) | |||||
| treatment | virus infection | RABV12h/RABV48h | treatment: CVS11 12 and 48(2vs2) | |||||
| treatment | virus infection | RABV24h/RABV48h | treatment: CVS11 24 and 48(4vs2) | |||||
| GSE48579 | GPL17873 | Mus musculus | miRNA | 20 | cell type | microglia/macrophage | cell_type: microglia and macrophage(9vs7) | |
| cell type | microglia/neuron | cell_type: microglia and PrimaryNeuron(9vs4) | ||||||
| GSE49330 | GPL14613 | Mus musculus | miRNA | 9 | treatment | microglia polarized | IL4/LPS | stimulation: IL4 and LPS(3vs3) |
| treatment | microglia polarized | IL4/PBS | stimulation: IL4 and PBS(3vs3) | |||||
| treatment | microglia polarized | LPS/PBS | stimulation: LPS and PBS(3vs3) | |||||
| GSE57410 | GPL16384 | Homo sapiens | miRNA | 18 | treatment | virus infection | JEV/mock | treatment: JEV and mock(9vs9) |
| treatment | virus infection | JEV6h/mock6h | time: 6h JEV and mock(3vs3) | |||||
| treatment | virus infection | JEV24h/mock24h | time: 24h JEV and mock(3vs3) | |||||
| treatment | virus infection | JEV48h/mock48h | time: 48h JEV and mock(3vs3) | |||||
| treatment | virus infection | JEV6h/JEV24h | treatment: JEV 6h and 24h(3vs3) | |||||
| treatment | virus infection | JEV6h/JEV48h | treatment: JEV 6h and 48h(3vs3) | |||||
| treatment | virus infection | JEV24h/JEV48h | treatment: JEV 24h and 48h(3vs3) | |||||
| GSE98143 | GPL17912 | Mus musculus | miRNA | 6 | cell type | microglia/macrophage | cell_type: microglia and macrophages(2vs4) | |
| GSE122663 | GPL16331 | Mus musculus | miRNA | 18 | disease | control/AD | strain: B6C3F1 and P301S (PS19)(8vs10) | |
| Sex | male/female | sex: B6C3F1 Male and Female(4vs4) | ||||||
| Sex | Admale/Adfemale | sex: P301S (PS19) Male and Female(5vs5) | ||||||
| GSE123262 | GPL17021 | Mus musculus | miRNA | 18 | treatment | immunosuppress | CBD/CBD_LPS | treatment: CBD and CBD_LPS(3vs3) |
| treatment | immunosuppress | THC/THC_LPS | treatment: THC and THC_LPS(3vs3) | |||||
| treatment | immunosuppress | CBD/control | treatment: CBD and Ctrl(3vs3) | |||||
| treatment | immunosuppress | CBD/LPS | treatment: CBD and LPS(3vs3) | |||||
| treatment | immunosuppress | CBD/THC | treatment: CBD and THC(3vs3) | |||||
| treatment | immunosuppress | control/LPS | treatment: Ctrl and LPS(3vs3) | |||||
| treatment | immunosuppress | control/THC | treatment: Ctrl and THC(3vs3) | |||||
| treatment | immunosuppress | LPS/THC | treatment: LPS and THC(3vs3) | |||||
| treatment | immunosuppress | CBD_LPS/THC_LPS | treatment: CBD_LPS and THC_LPS(3vs3) | |||||
| GSE133997 | GPL21265 | Mus musculus | miRNA | 12 | treatment | brain injury | control/rmTBI | treatment: control and rmTBI(3vs9) |
| treatment | brain injury | rmTBI3d/rmTBI14d | time: rmTBI 3d and 14d(3vs3) | |||||
| treatment | brain injury | rmTBI3d/rmTBI42d | time: rmTBI 3d and 42d(3vs3) | |||||
| treatment | brain injury | rmTBI14d/rmTBI42d | time: rmTBI 14d and 42d(3vs3) | |||||
| GSE99216 | GPL15691 | Mus musculus | lncRNA | 6 | treatment | microglia polarized | control/IL4 | cell_type: Resting and Il4(3vs3) |
brain tissue profiles statistic
| Dataid | subDataid | Species | RNA | Sample | Group_1 | Group_2 |
|---|---|---|---|---|---|---|
| TCGA-LGG | Homo sapiens | mRNA | 521 | disease | glioma | |
| TCGA-LGG | Homo sapiens | miRNA | 521 | disease | glioma | |
| CGGA | Homo sapiens | mRNA | 159 | disease | glioma | |
| CGGA | Homo sapiens | miRNA | 159 | disease | glioma | |
| GSE103229_1 | GSE103227 | Homo sapiens | mRNA | 5 | normal | |
| GSE103229_1 | GSE103228 | Homo sapiens | miRNA | 5 | normal | |
| GSE103229_2 | GSE103227 | Homo sapiens | mRNA | 5 | disease | GBM |
| GSE103229_2 | GSE103228 | Homo sapiens | miRNA | 5 | disease | GBM |
| GSE104514_1 | Mus musculus | mRNA | 12 | normal | wide type | |
| GSE104514_1 | Mus musculus | miRNA | 12 | normal | wide type | |
| GSE104514_2 | Mus musculus | mRNA | 12 | disease | AD | |
| GSE104514_2 | Mus musculus | miRNA | 12 | disease | AD | |
| GSE132177_1 | Mus musculus | mRNA | 6 | normal | wide type | |
| GSE132177_1 | Mus musculus | miRNA | 6 | normal | wide type | |
| GSE132177_2 | Mus musculus | mRNA | 6 | disease | AD | |
| GSE132177_2 | Mus musculus | miRNA | 6 | disease | AD | |
| GSE151567_1 | GSE151565 | Mus musculus | mRNA | 78 | normal | cortex |
| GSE151567_1 | GSE151566 | Mus musculus | miRNA | 78 | normal | cortex |
| GSE151567_2 | GSE151565 | Mus musculus | mRNA | 72 | normal | hypothalamus |
| GSE151567_2 | GSE151566 | Mus musculus | miRNA | 72 | normal | hypothalamus |
| GSE151567_3 | GSE151565 | Mus musculus | mRNA | 43 | normal | striatum |
| GSE151567_3 | GSE151566 | Mus musculus | miRNA | 43 | normal | striatum |
| GSE15745_1 | Homo sapiens | mRNA | 141 | normal | cerebellum | |
| GSE15745_1 | Homo sapiens | miRNA | 141 | normal | cerebellum | |
| GSE15745_2 | Homo sapiens | mRNA | 141 | normal | frontal cortex | |
| GSE15745_2 | Homo sapiens | miRNA | 141 | normal | frontal cortex | |
| GSE15745_3 | Homo sapiens | mRNA | 140 | normal | pons | |
| GSE15745_3 | Homo sapiens | miRNA | 140 | normal | pons | |
| GSE15745_4 | Homo sapiens | mRNA | 142 | normal | temporal cortex | |
| GSE15745_4 | Homo sapiens | miRNA | 142 | normal | temporal cortex | |
| GSE21687 | Homo sapiens | mRNA | 62 | disease | ependynoma | |
| GSE21687 | Homo sapiens | miRNA | 62 | disease | ependynoma | |
| GSE25632 | GSE25630 | Homo sapiens | mRNA | 21 | disease | GBM |
| GSE25632 | GSE25631 | Homo sapiens | miRNA | 21 | disease | GBM |
| GSE62699_1 | Homo sapiens | mRNA | 18 | normal | ||
| GSE62699_1 | Homo sapiens | miRNA | 18 | normal | ||
| GSE62699_2 | Homo sapiens | mRNA | 18 | disease | alcohol dependence | |
| GSE62699_2 | Homo sapiens | miRNA | 18 | disease | alcohol dependence | |
| GSE65776_1 | GSE65770 | Mus musculus | mRNA | 24 | normal | wide type,cortex |
| GSE65776_1 | GSE65769 | Mus musculus | miRNA | 24 | normal | wide type,cortex |
| GSE65776_2 | GSE65770 | Mus musculus | mRNA | 144 | disease | HD |
| GSE65776_2 | GSE65769 | Mus musculus | miRNA | 144 | disease | HD |
| GSE65776_3 | GSE65774 | Mus musculus | mRNA | 16 | normal | wide type,striatum |
| GSE65776_3 | GSE65773 | Mus musculus | miRNA | 16 | normal | wide type,striatum |
| GSE65776_4 | GSE65774 | Mus musculus | mRNA | 192 | disease | HD |
| GSE65776_4 | GSE65773 | Mus musculus | miRNA | 192 | disease | HD |
| GSE73508_1 | GSE73468 | Mus musculus | mRNA | 24 | normal | wide type,cerebellum |
| GSE73508_1 | GSE73505 | Mus musculus | miRNA | 24 | normal | wide type,cerebellum |
| GSE73508_2 | GSE73468 | Mus musculus | mRNA | 142 | disease | HD |
| GSE73508_2 | GSE73505 | Mus musculus | miRNA | 142 | disease | HD |
| GSE73508_3 | GSE73503 | Mus musculus | mRNA | 24 | normal | wide type,hippocampus |
| GSE73508_3 | GSE73507 | Mus musculus | miRNA | 24 | normal | wide type,hippocampus |
| GSE73508_4 | GSE73503 | Mus musculus | mRNA | 144 | disease | HD |
| GSE73508_4 | GSE73507 | Mus musculus | miRNA | 144 | disease | HD |
| GSE86615_1 | GSE86579 | Rattus norvegicus | mRNA | 5 | normal | |
| GSE86615_1 | GSE86614 | Rattus norvegicus | miRNA | 5 | normal | |
| GSE86615_2 | GSE86579 | Rattus norvegicus | mRNA | 6 | disease | fluid-percussion injury |
| GSE86615_2 | GSE86614 | Rattus norvegicus | miRNA | 6 | disease | fluid-percussion injury |
| GSE90962_1 | Mus musculus | mRNA | 6 | normal | ||
| GSE90962_1 | Mus musculus | miRNA | 6 | normal | ||
| GSE90962_2 | Mus musculus | mRNA | 6 | treatment | Subchronic Variable Stress | |
| GSE90962_2 | Mus musculus | miRNA | 6 | treatment | Subchronic Variable Stress |